The global market for smart pills reached $720 million in 2015. This market is expected to increase from $850 million in 2016 to $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 21.1% for 2016-2021.
Report Scope:
Smart pills include smart ingestible pill-size devices and technologies (e.g., capsule endoscopy, pill-size drug/device combination–based ingestible electronic tablets, microsize capsules for patient monitoring, etc.), which are relatively new and more advanced and give better outcomes in the diagnosis, drug delivery, treatment adherence, health monitoring, and management associated with various diseases. This report is an analytical business tool whose primary purpose is to describe the thorough evaluation of the global market for smart pills. The format of the study is organized around the following:
- Detailed description of smart pills and technologies.
- Demographics and cost burden of targeted diseases.
- Regulatory structure.
- Market characterization, unmet need, market size, and segmentation.
- Market drivers and restraints.
- Detailed market projections through 2021.
- Competition and market shares.
- Pricing and reimbursement.
- Description of marketed and pipeline (R&D) products along with information about their regulatory status and clinical trials.
- Observations and conclusions regarding the future of ingestible smart pills.
- Profiles of market participants and associations.
Report Includes:
- An overview of global market for smart pills and technologies.
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Assessment of smart pills systems and technology markets, including market growth drivers, restraints and shares.
- Information on the regulatory structure, major developments influencing the market and the long-term outlook.
- Analyses of segments within the overall market including capsule endoscopy systems, gastrointestinal monitoring system, diagnosis and monitoring.
- Evaluation of industry activity, including licensing agreements, partnerships, and merger and acquisitions.
- Profiles of major players in the industry.
Report Summary
In 2016, the U.S. accounted for about 55.1% of the global smart pills market, or $468 million. The U.S. market should reach $1.2 billion by 2021, increasing at a compound annual growth rate (CAGR) of 20.6% from 2016 through 2021. Those wishing to invest in the smart pills market ought to strongly consider high-growth application areas such as capsule endoscopy, patient-monitoring and drug-delivery smart pills. Most of these applications are expected to grow with high double-digit growth rates in the next five years. The increasing burden of GI disorders, cancer and other chronic diseases, and the adoption of advanced ingestible medical sensor technologies for patient monitoring and drug delivery are the key growth drivers behind the high forecast growth.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Target Diseases and Disorders
Chapter 4 Gastrointestinal Capsule Endoscopy
Chapter 5 Smart Pills for Patient Monitoring
Chapter 6 Smart Pills for Drug Delivery
Chapter 7 Market Size and Growth Analysis
Chapter 8 Competitive Landscape in Smart Pills Market
Chapter 9 Market Strategy
Chapter 10 Regulatory Structure
Chapter 11 Pricing and Reimbursement
Chapter 12 Outlook for Smart Pills and Technologies
Chapter 13 Company Profiles
Chapter 14 Appendix A Acronyms
Chapter 15 Appendix B Professional Organizations
Gastrointestinal/Digestive Diseases
Epidemiology and Economic Burden
Mortality
Common Gastrointestinal Diseases and Disorders
Inflammatory Bowel Disease (IBD)
Disease Overview
Epidemiology and Economic Burden
Diagnosis and Treatment
Ulcer Disease
Disease Overview
Epidemiology and Economic Burden
Diagnosis and Treatment
Esophagitis/Esophageal Diseases
Disease Overview
Epidemiology and Economic Burden
Diagnosis and Treatment
Gastroesophageal Reflux Disease (GERD)
Disease Overview
Epidemiology and Economic Burden
Diagnosis and Treatment
Obscure Gastrointestinal Bleeding
Disease Overview
Epidemiology and Economic Burden
Diagnosis and Treatment
Celiac Disease
Disease Overview
Epidemiology and Economic Burden
Diagnosis and Treatment
Digestive System Cancer
Colorectal Cancer
Disease Overview
Epidemiology and Economic Burden
Mortality
Diagnosis and Treatment
Small-bowel Tumors/Small-bowel Diseases
Disease Overview
Epidemiology and Economic Burden
Diagnosis and Treatment
Other Chronic Disorders
Obesity
Disease Overview
Measuring Obesity
Types of Obesity and Risk Factors
Economic Burden
Epidemiology
Diabetes
Disease Overview
Disease Symptoms and Risk Factors
Epidemiology and Economic Burden
Stroke
Disease Overview
Epidemiology and Economic Burden
Hypertension
Disease Overview
Epidemiology and Economic Burden
Capsule Endoscopy
Historic Overview
Capsule Endoscopy
Capsule Endoscope Components
Video Capsule Endoscope
Data Recorder
Workstation
Sensor and Software
Target Indications
Obscure Gastrointestinal Bleeding
Inflammatory Bowel Disease (IBD)
Small-bowel Polyps and Neoplasia
Celiac Disease
Other Indications
Contraindications
Limitations and Risks
Risks
Limitations
Capsule Retention
Control of Capsule
Poor Visualization
Incomplete Examination
Clinical Limitations
Cost-effectiveness
Types of Capsule Endoscopy
Small-bowel Video Capsule Endoscopy
Introduction
Procedure
Target Indications
Esophageal Video Capsule Endoscopy
Introduction
Procedure
Target Indications
Colon Capsule Endoscopy
Introduction
Procedure
Target Indications
Key Marketed and Pipeline Products
Marketed Products
CapsoCam Wire-Free Capsule Endoscopy (CapsoVision)
PillCam SB 3 (Given Imaging, a Subsidiary of Medtronic)
PillCam ESO 2 (Given Imaging, a Subsidiary of Medtronic)
PillCam COLON 2 (Given Imaging, a Subsidiary of Medtronic)
PillCam UGI Capsule (Given Imaging, a subsidiary of Medtronic)
Agile Patency Capsule (Second Generation) (Given Imaging, a Subsidiary of Medtronic)
Olympus ENDOCAPSULE (Olympus Corp.)
OMOM Pill (Chongqing Jinshan Science & Technology)
MiroCam (IntroMedic)
R&D Pipeline Products
PillCam for Ulcerative Colitis/Crohn’s Disease (Medtronic)
PillCam SBC System (Medtronic)
Check-Cap Capsule (Check-Cap)
Magnetically Guided Capsule (MGCE) (Olympus)
Future Developments
Target Indications
Gastroparesis
Other Gastrointestinal Motility Disorders
Chronic Constipation
Intestinal Dysmotility
Types and Applications of Smart Pills for Patient Monitoring
Monitoring Smart Pills (pH, Temperature, Pressure)
Drug-adherence Smart Pills
Key Marketed and Pipeline Products
SmartPill Motility Testing System (Medtronic)
Proteus Patch Including Ingestible Sensor (Proteus Digital Health)
OMOM pH Capsule Monitoring System (Chongqing Jinshan Science & Technology)
ABILIFY Smart Pill (ABILIFY Pill + Proteus Ingestible Sensor) (Proteus Digital Health and Otsuka Pharmaceuticals)
Smart Pill (Novartis Drugs + Proteus Ingestible Sensor) (Proteus Digital Health and Novartis)
Future Developments
Smart Pills for Oral Drug Delivery
Market Need for Drug-delivery Smart Pills
Target Gastrointestinal Diseases and Indications
Inflammatory Bowel Syndrome or Crohn’s Disease
Ulcerative Colitis
Gastroesophageal Reflux Disease
Stomach Disease
Chronic Gastrointestinal Disorders
Diverticular Disease
Bowel Tumors
Characteristics of Drug-delivery Smart Pills
Types of Drug-release Mechanisms
Passive Release Mechanisms
Active Release Mechanisms
Capsule Navigation
Passive Locomotion
Active Locomotion
Marketed and R&D Pipeline Products
IntelliCap (Medimetrics, Supported by Philips Research)
IntelliCap CR
IntelliCap FR
Novartis Robotic Pill (Novartis and Rani Therapeutics)
Novartis Smart Pill (Novartis and Proteus Digital)
Hydrophilic Sandwich (HS) (Bio-Images Research)
Future Developments
Market Size and Growth Analysis by Region
Market Size and Growth Analysis by Application
Market Growth Drivers and Restraints
Gastrointestinal Capsule Endoscopy
Smart Pills for Patient Monitoring
Smart Pills for Drug Delivery
Mergers and Acquisitions in Smart Pills Market
Recent Mergers and Acquisitions
Medtronic Acquired Covidien
Covidien Acquired Given Imaging
Given Imaging Acquired SmartPill's SmartPill GI Monitoring System
Given Imaging Acquired Sierra Scientific
Given Imaging Acquired Medtronic's Bravo Ph Monitoring System
Future Strategic Landscape
Regulatory Background
Regulatory Systems for Drug/Device Combination Products
Regulatory Systems for Medical Devices and Drugs
Regulatory Systems for Medical Devices by Region
U.S.
European Union
Japan
Other Asia Countries
China
Hong Kong
Korea
Taiwan
India
U.S. FDA Technical Considerations
FDA Policy for Low-risk and General Wellness Devices
FDA Recalls and Safety Alerts
Regulatory Systems for Drugs by Region
U.S.
Europe
Regulatory Procedures for Drugs in Europe
National Authorization Procedure
Centralized Procedure
Decentralized Procedure
Mutual Recognition Procedure
Japan
Regulatory Systems for Smart Pills
Old Drug, New Medical Device
Old Drug, Old Medical Device
New Drug, Old Medical Device
New Drug, New Medical Device
U.S.
Medical Devices
Pharmaceuticals
Europe
Medical Devices
Pharmaceuticals
Japan
Medical Devices
Pharmaceuticals
Other Asia Countries
Major Developments to Influence the Market
Technological Developments: Smart Ingestible Pill-size Medical Sensors and Software Applications
Social Developments: Social Media and Rise of Smartphone Use
Demographic and Economic Trends: Income Growth in Developing Markets
Long-term Outlook for Smart Pills
BIO-IMAGES RESEARCH LTD.
BOSTON SCIENTIFIC
CAPSOVISION INC.
CERNER CORP.
CHECK-CAP LTD.
CHONGQING JINSHAN SCIENCE & TECHNOLOGY (GROUP) CO. LTD.
FUJIFILM HOLDINGS CORP.
GE HEALTHCARE
GELESIS
GIVEN IMAGING INC. (SUBSIDIARY OF MEDTRONIC)
INTROMEDIC CO. LTD.
KARL STORZ GMBH & CO. KG
MEDIMETRICS PERSONALIZED DRUG DELIVERY BV
MEDIVATORS INC. (SUBSIDIARY OF CANTEL MEDICAL)
MEDTRONIC
NOVARTIS
OLYMPUS CORP.
PENTAX MEDICAL CO.
PHILIPS HEALTHCARE
PROTEUS DIGITAL HEALTH
RANI THERAPEUTICS
SMARTPILL CORP. (SUBSIDIARY OF MEDTRONIC)
STRYKER
SYNECTICS MEDICAL LTD. (TRADING AS SYNMED)
American Association for Cancer Research (AACR)
American Gastroenterological Association (AGA)
American Society for Gastrointestinal Endoscopy (ASGE)
Center for Drug Evaluation and Research (CDER)
Center for Devices and Radiological Health (CDRH)
Center for Medicare and Medicaid Services (CMS)
European Databank for Medical Devices (EUDAMED)
Food and Drug Administration (FDA or USFDA)
Global Cancer Foundation
Hormone Foundation
International Diabetes Federation (IDF)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
National Center for Biotechnology Information (NCBI)
National Institute of Aging (NIA)
Pharmaceuticals and Medical Devices Agency (PMDA)
World Cancer Research Fund International
World Gastroenterology Organisation (WGO)
World Health Organization (WHO)
Type 1 Diabetes
Type 2 Diabetes
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
Best quality reports based on various authentic and accurate data findings.
Your personal and confidential information is safe and secure.
Trends Market Research © Copyright 2020. All Rights Reserved.